New First-Line Option for Pancreatic Cancer Approved
(MedPage Today) -- The FDA approved irinotecan liposome (Onivyde) in combination with oxaliplatin, leucovorin, and fluorouracil (NALIRIFOX) for the first-line treatment of metastatic pancreatic adenocarcinoma, the agency announced on Tuesday....
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: Adenocarcinoma | American Health | Cancer | Cancer & Oncology | Eloxatin | International Medicine & Public Health | Pancreas | Pancreatic Cancer